Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

McGill University Health Centre/Research Institute of the McGill University Health Centre: Clinical Trials & FDA Approval Profile

McGill University Health Centre/Research Institute of the McGill University Health Centre (Global / Institutional) sponsors 35 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 13 active protocols (12 recruiting now), 7 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)17.1%
Median Closed Enrollment vs National (145 pts)55 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for McGill University Health Centre/Research Institute of the McGill University Health Centre
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)35
Active Pipeline (Recruiting Now)13 (12)
Completed vs Stopped Early7 / 6 (17.1%)
Median Closed Actual Enrollment55 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With McGill University Health Centre/Research Institute of the McGill University Health Centre
Hospital Research SiteLocationShared Protocols
McGill University Health CentreMontreal, Quebec11
University of AlbertaEdmonton, Alberta2
University Health NetworkToronto, Ontario2

Explore interactive annual charts and M&A subsidiary rollups in the McGill University Health Centre/Research Institute of the McGill University Health Centre Interactive Dossier, benchmark peers in Infectious Disease and Vaccines, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI